Draw/line
Education and research purposes only, not medical advice. Unapproved compounds are not for human consumption. Check every result with your prescriber. Disclaimer Research and education only. Not medical advice. Disclaimer
Home / Compounds / Metformin

Metformin

Metformin (Glucophage): approved use in type 2 diabetes, the lactic acidosis boxed warning, the 2020 NDMA recalls and anti-aging claims.

FDA-approved, prescription only · Evidence grade A · Reviewed

Approved and studied uses
  • FDA-approvedType 2 diabetesGlucophage and generics
  • Not approvedWeight loss and agingNot approved uses

Metformin (Glucophage, Glucophage XR). Biguanide (diabetes drug).

AFDA-approved, prescription only. Evidence grade A: approved, large human trials.

What is Metformin?

Metformin is a pill that lowers blood sugar and is a common first treatment for type 2 diabetes. It is also promoted online for weight loss and longevity.

Is Metformin FDA-approved?

Glucophage was first approved in the United States in 1995, as an addition to diet and exercise to control blood sugar in type 2 diabetes. Generics are widely sold. In 2020 FDA found elevated levels of NDMA, a likely cancer-causing impurity, in some extended-release metformin, and companies recalled many lots; FDA did not find it in the immediate-release products it tested. Weight loss and aging are not approved uses.

What does the evidence show for Metformin?

Strong trial evidence in type 2 diabetes. In the NIH Diabetes Prevention Program, metformin lowered the chance of developing type 2 diabetes by 31% compared with placebo in high-risk adults, less than the lifestyle program did. No approval or proven benefit exists for aging.

What are the known risks of Metformin?

The label carries a boxed warning for lactic acidosis: reported cases have caused death, low body temperature, low blood pressure and slow, irregular heart rhythms. Risk rises with kidney problems, iodinated contrast scans, surgery, heavy alcohol use and liver disease. It can lower vitamin B12 and can cause low blood sugar when combined with insulin or sulfonylurea-type drugs. Stomach upset is common. Metformin is not on the 2026 WADA Prohibited List.

How is Metformin measured?

A tablet, so there is nothing to draw or calculate.

Sources: FDA label: Glucophage and Glucophage XR (metformin); FDA: updates and press announcements on NDMA in metformin; FDA: questions and answers on NDMA in metformin; NIDDK: Diabetes Prevention Program; WADA: 2026 Prohibited List. This profile does not recommend any dose or use.

For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.

Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.